 |
Journal articles
The road to clinical use of high-intensity focused ultrasound for liver cancer: technical and clinical consensus
Jean-Francois Aubry
1, 2
Kim Pauly
3
Chrit Moonen
4
Gail Ter Haar
5
Mario Ries
4
Rares Salomir
6
Sham Sokka
7
Kevin Sekins
8
Yerucham Shapira
9
Fangwei Ye
10
Heather Huff-Simonin
11
Matt Eames
11
Arik Hananel
11, *
Neal Kassell
11
Alessandro Napoli
12
Joo Hwang
13
Feng Wu
14
Lian Zhang
15
Andreas Melzer
16
Young-Sun Kim
17
Wladyslaw Gedroyc
18, 19
*
Corresponding author
Jean-Francois Aubry 1, 2
Author IdHAL : jfaubry ORCID : https://orcid.org/0000-0003-2644-3945
Kim Butts Pauly 3
Author
Chrit Moonen 4
Author
Gail Ter Haar 5
Author
Arik Hananel 11
Correspondent author
Neal Kassell 11
Author
Alessandro Napoli 12
Author
Joo Ha Hwang 13
Author
Wladyslaw Gedroyc 18, 19
Author
1
Department of Radiation Oncology (Charlottesville, VA - United States)
- University of Virginia [Charlottesville] (P.O. Box 400229, Charlottesville, VA 22904-4229 - United States)
2
IL - Institut Langevin - Ondes et Images (UMR7587) (ESPCI, 1 Rue Jussieu 75238 Paris Cedex 05 - France)
- ESPCI Paris - Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (10 rue Vauquelin, 75231 Paris cedex 05 - France)
- PSL - Université Paris sciences et lettres (60 rue Mazarine 75006 Paris - France)
- SU - Sorbonne Université (21 rue de l’École de médecine - 75006 Paris - France)
- CNRS - Centre National de la Recherche Scientifique : UMR_7587 (France)
- UP - Université de Paris (85 boulevard Saint-Germain 75006 Paris - France)
3
RSL - Radiological Sciences Laboratory [Stanford] (Stanford University, Stanford Medicine, Department of Radiology, Lucas Center, 1201 Welch Rd, Stanford CA, 94305 - United States)
- Department of Radiology [Stanford] (Stanford University, Stanford Medicine - United States)
- Stanford Medicine (Stanford University - United States)
- Stanford University (450 Serra Mall, Stanford, CA 94305-2004 - United States)
- Stanford Medicine (Stanford University - United States)
4
Imaging Division (Amsterdam - Netherlands)
- University Medical Center [Utrecht] (Heidelberglaan 100 3584 CX Utrecht - Netherlands)
5
Division of Radiotherapy and Imaging (Sutton, Surrey - United Kingdom)
- The Institute of Cancer Research (France)
- Royal Marsden Hospital (France)
6
Faculty of Medicine (Geneva - Switzerland)
- University of Geneva [Switzerland] (Bd du Pont-d'Arve 40, CH-1211 Geneva 4 - Switzerland)
10
Chongqing Haifu Medical Technology Co. (Chongqing - China)
11
Focused Ultrasound Foundation (Charlottesville, VA - United States)
- Focused Ultrasound Foundation (France)
12
Università degli Studi di Roma "La Sapienza" = Sapienza University [Rome] (Piazzale Aldo Moro 5, 00185 Roma - Italy)
13
Digestive Disease Center (Seattle, WA - United States)
- University of Washington [Seattle] (Seattle, Washington 98105 - United States)
14
Institute of Ultrasonic Engineering in Medicine (Chongqing - China)
- Chongqing Medical University (France)
15
Clinical Center for Tumor Therapy (Chongqing - China)
16
Institute for Medical Science and Technology (Dundee, Scotland - United Kingdom)
- University of Dundee (University of Dundee Nethergate Dundee Scotland, UK DD1 4HN - United Kingdom)
17
Department of Radiology (Samsung Medical Center, Seoul - South Korea)
- SKKU - Sungkyunkwan University [Suwon] (Suwon Gyeonggi-Do 440-746 - South Korea)
18
Department of Medicine (United Kingdom)
- Imperial College London (South Kensington Campus, London SW7 2AZ - United Kingdom)
19
Saint Mary's Hospital [London] (Praed St, W2 1NY, London - United Kingdom)
- St Mary's Hospital [London] (Praed Street, London W2 1NY - United Kingdom)
Abstract : Clinical use of high-intensity focused ultrasound (HIFU) under ultrasound or MR guidance as a non-invasive method for treating tumors is rapidly increasing. Tens of thousands of patients have been treated for uterine fibroid, benign prostate hyperplasia, bone metastases, or prostate cancer. Despite the methods' clinical potential, the liver is a particularly challenging organ for HIFU treatment due to the combined effect of respiratory-induced liver motion, partial blocking by the rib cage, and high perfusion/flow. Several technical and clinical solutions have been developed by various groups during the past 15 years to compensate for these problems. A review of current unmet clinical needs is given here, as well as a consensus from a panel of experts about technical and clinical requirements for upcoming pilot and pivotal studies in order to accelerate the development and adoption of focused ultrasound for the treatment of primary and secondary liver cancer.
Document type :
Journal articles
Domain :
Complete list of metadata
https://www.hal.inserm.fr/inserm-00851863
Contributor : Ed. Bmc Connect in order to contact the contributor
Submitted on : Monday, August 19, 2013 - 6:06:16 AM
Last modification on : Wednesday, November 17, 2021 - 12:33:46 PM
Long-term archiving on: : Wednesday, November 20, 2013 - 4:13:56 AM
Contributor : Ed. Bmc Connect in order to contact the contributor
Submitted on : Monday, August 19, 2013 - 6:06:16 AM
Last modification on : Wednesday, November 17, 2021 - 12:33:46 PM
Long-term archiving on: : Wednesday, November 20, 2013 - 4:13:56 AM
Files
2050-5736-1-13.pdf
Publisher files allowed on an open archive
Identifiers
- HAL Id : inserm-00851863, version 1
Collections
INSERM | CNRS | PARISTECH | SORBONNE-UNIVERSITE | SU-SCIENCES | UNIV-PARIS | UP-SCIENCES | PSL | ESPCI-PSL | ESPCI | SU-TI | UPMC | LANGEVIN
Citation
Jean-Francois Aubry, Kim Pauly, Chrit Moonen, Gail Ter Haar, Mario Ries, et al.. The road to clinical use of high-intensity focused ultrasound for liver cancer: technical and clinical consensus. Journal of Therapeutic Ultrasound, BioMed Central, 2013, 1 (1), pp.13. ⟨inserm-00851863⟩
Metrics
Record views
1950
Files downloads